Search
Alnylam Pharmaceuticals Inc
ALNYAdd to Watchlist
293.520USD
+2.150+0.74%
Close 06/29, 16:00（ET）Quotes delayed by 15 min
39.17BMarket Cap
71.84P/E TTM
Alnylam Pharmaceuticals Inc Earnings Date
Period
FY2025 Earnings Date
Revenue(YoY)
3.71B
65.19%
EPS(YoY)
2.39
209.91%
Analyst Rating
BUY
2026-06-29
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of Alnylam Pharmaceuticals Inc?
According to Alnylam Pharmaceuticals Inc's FY2025 earnings report, its total revenue reached 3.71B, with a year-on-year change of 65.19.
What are the current assets of Alnylam Pharmaceuticals Inc?
According to Alnylam Pharmaceuticals Inc's FY2025 earnings report, its current assets were 4.05B, with a year-on-year change of 22.92.
What are the total assets of Alnylam Pharmaceuticals Inc?
According to Alnylam Pharmaceuticals Inc's FY2025 earnings report, its total assets of Alnylam Pharmaceuticals Inc were 4.97B, with a year-on-year change of 17.13.
What are the total liabilities of Alnylam Pharmaceuticals Inc?
According to Alnylam Pharmaceuticals Inc's FY2025 earnings report, its total liabilities of Alnylam Pharmaceuticals Inc were 4.18B, with a year-on-year change of 0.10.
What is the total equity of Alnylam Pharmaceuticals Inc?
According to Alnylam Pharmaceuticals Inc's FY2025 earnings report, its total equity of Alnylam Pharmaceuticals Inc was 789.18M, with a year-on-year change of 1076.33.
What is the net investment of Alnylam Pharmaceuticals Inc?
According to Alnylam Pharmaceuticals Inc's FY2025 earnings report, its net investment of Alnylam Pharmaceuticals Inc was 436.33M, with a year-on-year change of 473.44.
What is the net financing of Alnylam Pharmaceuticals Inc?
According to Alnylam Pharmaceuticals Inc's FY2025 earnings report, its net financing of Alnylam Pharmaceuticals Inc was -305.19M, with a year-on-year change of -203.75.
What is the Earnings Per Share (EPS) of Alnylam Pharmaceuticals Inc?
According to Alnylam Pharmaceuticals Inc's FY2025 earnings report, its Earnings Per Share (EPS) was 2.39, with a year-on-year change of 209.91.
What is the net margin of Alnylam Pharmaceuticals Inc?
According to Alnylam Pharmaceuticals Inc's FY2025 earnings report, its net profit margin was 8.45, with a year-on-year change of 168.28.
What is the gross margin of Alnylam Pharmaceuticals Inc?
According to Alnylam Pharmaceuticals Inc's FY2025 earnings report, its gross margin was 81.64, with a year-on-year change of -4.64.
What is the debt-to-asset ratio of Alnylam Pharmaceuticals Inc?
According to Alnylam Pharmaceuticals Inc's FY2025 earnings report, its debt-to-asset ratio was 54.33, with a year-on-year change of -6.81.
What is the Return on Assets (ROA) of Alnylam Pharmaceuticals Inc?
According to Alnylam Pharmaceuticals Inc's FY2025 earnings report, its Return on Assets (ROA) was 6.82, with a year-on-year change of 198.87.
What is the operating profit of Alnylam Pharmaceuticals Inc?
According to Alnylam Pharmaceuticals Inc's FY2025 earnings report, its operating profit was 501.58M, with a year-on-year change of 383.56.
